- Home
- SMHI vs VTYX Comparison
SMHI vs VTYX Comparison
Compare SMHI & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- VTYX
- Stock Information
- Founded
- SMHI 1989
- VTYX 2018
- Country
- SMHI United States
- VTYX United States
- Employees
- SMHI N/A
- VTYX N/A
- Industry
- SMHI Marine Transportation
- VTYX Medicinal Chemicals and Botanical Products
- Sector
- SMHI Consumer Discretionary
- VTYX Health Care
- Exchange
- SMHI Nasdaq
- VTYX Nasdaq
- Market Cap
- SMHI 186.4M
- VTYX 154.9M
- IPO Year
- SMHI N/A
- VTYX 2021
- Fundamental
- Price
- SMHI $6.28
- VTYX $8.86
- Analyst Decision
- SMHI
- VTYX Buy
- Analyst Count
- SMHI 0
- VTYX 3
- Target Price
- SMHI N/A
- VTYX $12.50
- AVG Volume (30 Days)
- SMHI 66.0K
- VTYX 9.5M
- Earning Date
- SMHI 10-29-2025
- VTYX 11-06-2025
- Dividend Yield
- SMHI N/A
- VTYX N/A
- EPS Growth
- SMHI N/A
- VTYX N/A
- EPS
- SMHI N/A
- VTYX N/A
- Revenue
- SMHI $245,311,000.00
- VTYX N/A
- Revenue This Year
- SMHI N/A
- VTYX N/A
- Revenue Next Year
- SMHI $9.97
- VTYX N/A
- P/E Ratio
- SMHI N/A
- VTYX N/A
- Revenue Growth
- SMHI N/A
- VTYX N/A
- 52 Week Low
- SMHI $3.63
- VTYX $0.78
- 52 Week High
- SMHI $8.61
- VTYX $8.52
- Technical
- Relative Strength Index (RSI)
- SMHI N/A
- VTYX 83.25
- Support Level
- SMHI N/A
- VTYX $5.75
- Resistance Level
- SMHI N/A
- VTYX $7.50
- Average True Range (ATR)
- SMHI 0.00
- VTYX 0.66
- MACD
- SMHI 0.00
- VTYX 0.44
- Stochastic Oscillator
- SMHI 0.00
- VTYX 98.23
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.